TREM2 and prostate cancer: In a mouse model of prostate cancer, tumor cell-released apolipoprotein E (APOE) interacts with triggering receptor expressed on myeloid cells 2 (TREM2) on neutrophils, triggering the senescence process in neutrophils [59].